Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Penumbra, Inc.

PENNYSE
Healthcare
Medical - Devices
$340.68
$0.00(0.00%)
U.S. Market is Open • 14:02

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap13.3B
P/E Ratio80.90
EPS (TTM)$4.19
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$337.25
3 Months$339.01
1 Year Target$272.71

PEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Penumbra, Inc. (PEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $272.71.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 80.90 and a market capitalization of 13.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.40%
5-Day Change
0.14%
1-Month Change
-4.54%
3-Month Change
21.27%
6-Month Change
32.69%
Year-to-Date (YTD) Change
9.66%
1-Year Change
11.94%
3-Year Change
31.42%
5-Year Change
21.17%
All-Time (Max) Change
721.57%

Contact Information

510 748 3200
One Penumbra Place, Alameda, CA, 94502

Company Facts

45,000 Employees
IPO DateSep 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions